Depression is linked to dry eye disease symptoms in elderly patients

Article

A paper published in Investigative Ophthalmology and Visual Science has revealed an association between dry eye disease (DED) and depression in patients with a normal or slightly reduced tear production.

A paper published in Investigative Ophthalmology and Visual Science has revealed an association between dry eye disease (DED) and depression in patients with a normal or slightly reduced tear production.

The investigation led by Dr Joon Young Hyon, Department of Ophthalmology, Seoul National University Bundang Hospital, Korea, examined 657 Korean patients aged 65 years and over. A six-item Dry Eye Questionnaire was used to assess DED symptoms. The Schirmer test, fluorescein stain score and tear film break-up time (BUT) was used to evaluate DED signs. The Korean equivalent of the Short Geriatric Depression Scale (SGDS-K) was used to identify depression.

Binary logistic linear analysis highlighted the female sex, living in an urban area and a Schirmer score of less than 5 mm as factors contributing towards the risk of developing DED.

Depression was not affected by DED patients with a Schirmer score of less than 5 mm, but was affected by a Schirmer score of more than 5 mm. SGDS-K score was associated with several positive answers in the Dry Eye Questionnaire.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.